Apart from its cardiovascular effects, it is known that the angiotensin II/type 1 angiotensin II receptor (AT1R) pathway promotes local inflammation within the tumor microenvironment by affecting immune cells, mesangial cells, and vascular smooth muscle cells [51,52]. This evidence concerns the gene AGTR1 and neoplasm.